Sequana Medical Investor Presentation September 2021

Sequana Medical is developing innovative treatments for diuretic-resistant fluid overload conditions including liver disease-related malignant ascites and heart failure. The presentation covers the company's clinical programs, including the alfapump® system and DSR® therapy, along with regulatory status and strategic initiatives as of September 2021.